Tribulus Terrestris Saponin Capsule

(1) To evaluate the safety and efficacy of Tribulus terrestris saponin capsules in the treatment of patients in the recovery period (wind-phlegm-stasis syndrome) of cerebral infarction (stroke meridians) through a Phase IV clinical trial, with a focus on observing possible adverse reactions, including the type of adverse reactions, the incidence of adverse reactions, and the clinical manifestations and severity of adverse reactions; (2) To explore its possible mechanism of action in the treatment of patients in the recovery period (wind-phlegm-stasis syndrome) of cerebral infarction (stroke meridians).